Search for a command to run...
Dr Agarwals Eye Hospital Ltd. is currently positioned in a competitive landscape with significant peers showing strong financial metrics. While Dr Agarwals struggles with growth and profitability metrics, peers like Max Healthcare Institute and Apollo Hospitals demonstrate robust growth, profitability, and efficiency. Strategic value picks exist in Aster DM Healthcare and Fortis Healthcare despite their challenges in profitability, making them potentially attractive for investors seeking value at lower valuations.
Stocks | CMP | Market Cap | P/E | ROCE (%) | Debt/Equity |
---|---|---|---|---|---|
Dr Agarwals Eye Hospital Ltd. | ₹4,452.85 | ₹2,092.84Cr | 38.30 | - | - |
MAXHEALTH | ₹1,179.65 | ₹1,14,679.30Cr | 163.58 | 16.26% | 0.14 |
APOLLOHOSP | ₹7,676.95 | ₹1,10,383.03Cr | 85.15 | 21.19% | 0.67 |
FORTIS | ₹924.85 | ₹69,822.29Cr | 1094.63 | 12.01% | 0.11 |
MEDANTA | ₹1,395.25 | ₹37,474.60Cr | 81.26 | 20.50% | 0.10 |
NH | ₹1,784.05 | ₹36,459.02Cr | 84.56 | 21.62% | 0.61 |
ASTERDM | ₹605.10 | ₹30,225.53Cr | 5.05 | 11.46% | 0.19 |